← All entities
biowiki · neo4j · hierarchical clustering

Therapy Cluster Tree

The 150 most-cited of 13,066 Therapy entities, grouped by the diseases, genes and clinical metrics they appear alongside. No clinical taxonomy was supplied, yet checkpoint inhibitors, platinum chemotherapy and the GLP-1 class each fall out as their own branch.

Why this page — 1

See the shape of the category

Therapy is the fifth-largest category in the graph and nobody has looked at it whole. The tree shows which treatment families the corpus actually covers, and how much literature sits behind each one.

Why this page — 2

Feed the manual duplicate check

Two labels for one therapy end up adjacent here, because they are used in the same papers about the same diseases. The worklist below ranks those pairs so a human can merge or reject them one at a time — clustering proposes, a person decides.

Therapies charted
150of 13,066
Papers behind them
12,705
Profile dimensions
10,438co-occurring entities
Clusters
12Ward, k=12

How distance was measured

Scoring pairs by the papers they literally share does not work here: only 11% of the 11,175 pairs share even one paper, so nearly every distance is 1 and the tree collapses into a single 142-member blob with a handful of singletons. Instead each therapy is profiled by the other entities it co-occurs with — 11 types, from Disease and Gene to Clinical Metric — weighted log1p × IDF, L2-normalised, and joined with ward linkage. Two drugs that never share a paper still land together when they point at the same disease.

Cluster names are read off their members by hand; the branch structure itself is untouched output. Underlined therapies have a wiki page (101 of 150).

Near-duplicate worklist

Every pair whose names overlap — one contains the other, or they share a content word or a six-letter stem — ranked by how differently the two are actually used (87 pairs; closest 20 shown). A low distance next to an overlapping name is a merge candidate. A split badge means the two landed in different clusters, which usually argues against merging. Not every row is a duplicate: adjuvant therapy and neoadjuvant therapy rank high and are clinically distinct — that is the kind of false positive this list exists to put in front of a person.

DistanceLarger labelSmaller label Name match
0.449robot-assisted radical prostatectomy 27radical prostatectomy 21contains
0.581Endovascular Thrombectomy 23thrombectomy 21contains
0.612vaccination 65influenza vaccine 41vaccin…
0.623vaccination 65vaccine 65vaccin…
0.680adjuvant therapy 22neoadjuvant therapy 19contains
0.726vaccination 65COVID-19 vaccine 39vaccin…
0.772vaccine 65influenza vaccine 41contains
0.789vaccination 65HPV vaccine 40vaccin…
0.792anti-PD-1 therapy 79anti-PD-L1 61anti
0.808neoadjuvant immunochemotherapy 32neoadjuvant therapy 19neoadjuvantsplit
0.829monoclonal antibody 59neutralizing antibody 29antibody
0.847vaccine 65COVID-19 vaccine 39contains
0.851monoclonal antibody 59antibody-drug conjugate 36antibodysplit
0.857chemotherapy 203neoadjuvant chemotherapy 22contains
0.857Targeted Cancer Therapy 24Proteolysis-targeting chimeras 20target…
0.862fluorouracil 53cisplatin/fluorouracil 33contains
0.864chemotherapy 203Therapy 47containssplit
0.871influenza vaccine 41COVID-19 vaccine 39vaccine
0.876checkpoint inhibitor 282immune-checkpoint blockade 35checkpoint
0.883platinum-based chemotherapy 22platinum 18containssplit

The tree

Leaves at the right, root at the left; the further left two branches join, the less alike they are. Bars give each therapy's paper count.

0.00.51.11.62.1← merge distance (Ward)TherapyPapersCluster Checkpoint blockadePD-1 / PD-L1 axis and its combination partners12Radical prostatectomythe two prostate-surgery labels2Cytotoxic chemotherapy · PARPplatinum, fluoropyrimidine, DNA-damage targets21Surgery · chemo · radiationperioperative standard of care in solid tumours16EGFR · TKI targeted therapytyrosine-kinase inhibitors5Targeted · cell therapy · hemeCAR-T, ADCs, stem-cell transplant, precision radiation31Vaccines · antibody immunityimmunisation and neutralising antibodies9CardiometabolicGLP-1 · SGLT2 · mineralocorticoid receptor6Myeloma tripletdexamethasone · lenalidomide · bortezomib3Non-oncology general practiceinfection, metabolic, neuro, procedural34JAK inhibitors · type-2 inflammationatopic and myeloproliferative disease4Steroids · immunosuppressioncorticosteroids and B-cell depletion7anti-PD-1 therapy79immunotherapy121immune-checkpoint blockade35anti-PD-L161PD-1/PD-L1 blockade36nivolumab85ipilimumab33bevacizumab73atezolizumab52lenvatinib44checkpoint inhibitor282pembrolizumab89robot-assisted radical prostatectomy27radical prostatectomy21oxaliplatin41capecitabine26neoadjuvant or adjuvant chemotherapy39cisplatin/fluorouracil33taxane36combination drug20Caelyx49doxorubicin137sorafenib52cisplatin101docetaxel32fluorouracil53platinum18photothermal therapy33chemodynamic therapy20treatment of cancer41gene therapy34combination therapy44monotherapy39olaparib31PARP inhibitor21trastuzumab25adjuvant therapy22neoadjuvant therapy19surgical resection37chemotherapy203radiation therapy115surgery83neoadjuvant chemotherapy22paclitaxel65carboplatin46platinum-based chemotherapy22tislelizumab19durvalumab35chemoradiotherapy22tamoxifen23cetuximab18erlotinib23gefitinib21sirolimus41tyrosine-kinase inhibitor51osimertinib36neoadjuvant immunochemotherapy32salpingooophorectomy22Targeted Cancer Therapy24Proteolysis-targeting chimeras20zimberelimab19dasatinib22vandetanib20precision oncology26Targeted therapies59standard therapy31infection and vaccination18Chemoimmunotherapy32Bacillus Calmette-Guérin19CAR-T cells97antibody-drug conjugate36gemcitabine62peptide34cognitive behavioral therapy19Therapy47supportive care22androgen deprivation therapy26systemic therapy50Allogeneic hematopoietic stem cell tra…Allogeneic hematopoietic stem cell transplantation40ultra-low dose radiotherapy18proton therapy24Stereotactic radiosurgery23venetoclax44ibrutinib21methotrexate39intravitreal rituximab19calcineurin inhibitor18HPV vaccine40COVID-19 vaccine39vaccine65vaccination65influenza vaccine41Interferon gamma49immunization46monoclonal antibody59neutralizing antibody29glucagon-like peptide-1 agonist93semaglutide100tirzepatide44finerenone18sodium glucose cotransporter-2 (SGLT2)…sodium glucose cotransporter-2 (SGLT2) inhibitors65dapagliflozin31dexamethasone80lenalidomide28bortezomib26Endovascular Thrombectomy23thrombectomy21regenerative medicine26drug delivery system21vancomycin28doxycycline24antibiotic24liver transplantation38antisense oligonucleotide22pharmacotherapy22hemodialysis41pharmacologic and surgical management23Aged garlic extract43vitamin D34usual care31electroacupuncture20dolutegravir22sleeve gastrectomy19continuous positive airway pressure18statin36aspirin24fecal bacteriotherapy30melatonin22placebo capsules24metformin82Insulin Therapy51therapeutic agent20amphotericin B18adalimumab25donepezil20temozolomide42hypoxic-microenvironment-responsive th…hypoxic-microenvironment-responsive therapeutic strategy33single-nucleotide polymorphism25palbociclib21dupilumab26upadacitinib19ruxolitinib22Janus kinase inhibitors20glucocorticoid51corticosteroid30prednisone19rituximab62cyclophosphamide51intravenous immunoglobulin32methylprednisolone22